from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1246c/relE

LFCtreatmentdescriptionclass of inhibitor

-0.667

Amikacinug/mL Amikacintranslation

-0.837

Cap5-10ug/mL Capreomycintranslation

-0.516

Rox10-50 ug/mL Roxithromycintranslation

-0.285

SM2-5 ug/mL Streptomycintranslation

0.292

Tet5-10 ug/mL Tetracyclinetranslation

0.352

Rif0.2-5ug/mL Rifampicintranscription

-0.082

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.808

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.235

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.250

CPZ10-50 ug/mL Chlorpromazinerespiration

1.475

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.351

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.262

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.159

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.225

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.245

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.920

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.058

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.527

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.671

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.719

KCN5-20 ug/mL Potassium cyaniderespiration

0.103

NaN30.2-2 mM Sodium aziderespiration

1.814

Nigericin50 uM Nigericinrespiration

0.899

TRC10-150 ug/mL Triclosanrespiration

-0.206

TRZ10-25 ug/mL Thioridazinerespiration

0.000

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.225

menadione6-10 ug/mL Menadionerespiration

0.592

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.117

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.360

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.153

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.703

NRP_1Non-replicating persistence stage 1dosRassociated

-0.033

Amp0.2mg/mL AmpicillincellWall

-0.204

Cephalexin20-100 ug/mL CephalexincellWall

0.212

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.481

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.119

EMB10-20 ug/mL EthambutolcellWall

-0.111

Eta12-40 ug/mL EthionamidecellWall

-0.228

INH0.2-0.4 ug/mL IsoniazidcellWall

0.164

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.145

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.557

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.532

BZA0.12 mg/mL BenzamidearomaticAmides

-0.230

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.693

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.263

H2O24 mM hydrogen peroxideDNAdamaging

-0.192

Levo10 ug/mL LevofloxacinDNAdamaging

-0.467

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.971

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.300

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.716

UVUV-irradiationDNAdamaging

0.104

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.298

Antimycin12.5-50 ug/mL Antimycin A?

-0.294

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.407

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.069

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.767

PA8240.2-2 ug/mL PA-824?

0.630

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.024

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.700

Verapamil50 uM Verapamil?

0.208

mercaptoethanol2 mM 2-Mercaptoethanol?

0.220

methoxatin10-20 ug/mL Methoxatin?